Protara Therapeutics (TARA) Institutional Ownership

$3.90 -0.06 (-1.52%)

Closing price 08/20/2026 04:00 PM Eastern

Extended Trading

$3.89 -0.01 (-0.26%)

As of 08:43 AM Eastern

Compare

Current Institutional Ownership Percentage: 38.13%
Number of Institutional Buyers (last 12 months): 53
Total Institutional Inflows (last 12 months): $78.18M

Number of Institutional Sellers (last 12 months): 18
Total Institutional Outflows (last 12 months): $8.95M

Get TARA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TARA Institutional Buying and Selling by Quarter

Protara Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/18/2026	Public Employees Retirement System of Ohio	29,700	$113K	0.0%	N/A	0.050%
8/6/2026	Bank of New York Mellon Corp	137,689	$526K	0.0%	N/A	0.245%
7/8/2026	Assenagon Asset Management S.A.	59,954	$229K	0.0%	-89.4%	0.107%
5/19/2026	Bank of America Corp DE	925,918	$4.82M	0.0%	+86.7%	1.648%
5/19/2026	Janus Henderson Group PLC	5,207,011	$27.16M	0.0%	+1.3%	9.265%
5/18/2026	ADAR1 Capital Management LLC	940,512	$4.90M	0.3%	-17.3%	1.674%
5/16/2026	The Manufacturers Life Insurance Company	13,548	$71K	0.0%	+22.2%	0.024%
5/14/2026	Renaissance Technologies LLC	125,700	$655K	0.0%	-52.9%	0.228%
5/14/2026	Walleye Capital LLC	443,401	$2.31M	0.0%	+204.0%	0.805%
5/7/2026	Dimensional Fund Advisors LP	531,267	$2.77M	0.0%	+133.9%	0.965%
Get the Latest News and Ratings for TARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/5/2026	Bank of New York Mellon Corp	129,671	$676K	0.0%	+38.7%	0.236%
4/30/2026	AIGH Capital Management LLC	1,622,733	$8.45M	1.2%	N/A	2.947%
4/20/2026	Assenagon Asset Management S.A.	567,621	$2.96M	0.0%	+84.1%	1.050%
2/23/2026	Virtu Financial LLC	68,956	$368K	0.0%	N/A	0.134%
2/19/2026	Invesco Ltd.	17,514	$93K	0.0%	-30.4%	0.034%
2/18/2026	ADAR1 Capital Management LLC	1,136,799	$6.06M	0.4%	+3,127.4%	2.202%
2/18/2026	XTX Topco Ltd	115,363	$615K	0.0%	N/A	0.223%
2/18/2026	Sphera Funds Management LTD.	650,000	$3.46M	0.7%	N/A	1.259%
2/18/2026	Quadrature Capital Ltd	24,184	$129K	0.0%	+39.4%	0.047%
2/18/2026	Millennium Management LLC	753,302	$4.02M	0.0%	+9.5%	1.459%
2/18/2026	Janus Henderson Group PLC	5,141,616	$27.38M	0.0%	+21.5%	9.959%
2/18/2026	Engineers Gate Manager LP	21,886	$117K	0.0%	N/A	0.042%
2/18/2026	Catalio Capital Management LP	1,446,254	$7.71M	1.4%	-3.6%	2.801%
2/18/2026	Baker BROS. Advisors LP	971,614	$5.18M	0.0%	+81.0%	1.882%
2/18/2026	5AM Venture Management LLC	1,369,782	$7.30M	2.3%	+71.2%	2.653%
2/17/2026	ADAR1 Capital Management LLC	1,136,799	$6.06M	0.4%	+3,127.4%	2.202%
2/17/2026	Burkehill Global Management LP	450,000	$2.40M	0.2%	N/A	0.872%
2/17/2026	AQR Capital Management LLC	14,681	$78K	0.0%	N/A	0.028%
2/17/2026	Price T Rowe Associates Inc. MD	20,736	$111K	0.0%	+26.8%	0.040%
2/17/2026	Integral Health Asset Management LLC	2,250,000	$11.99M	0.6%	+60.7%	4.358%
2/17/2026	Adage Capital Partners GP L.L.C.	1,043,478	$5.56M	0.0%	N/A	2.021%
2/17/2026	Persistent Asset Partners Ltd	10,733	$57K	0.0%	N/A	0.021%
2/16/2026	Panagora Asset Management Inc.	43,796	$233K	0.0%	N/A	0.085%
2/16/2026	Maven Securities LTD	754,626	$4.02M	0.1%	N/A	1.462%
2/16/2026	Barclays PLC	55,057	$293K	0.0%	+21.0%	0.107%
2/13/2026	Marshall Wace LLP	584,528	$3.12M	0.0%	+104.7%	1.132%
2/13/2026	The Manufacturers Life Insurance Company	11,084	$59K	0.0%	N/A	0.021%
2/13/2026	Walleye Capital LLC	145,876	$778K	0.0%	N/A	0.283%
2/13/2026	Alyeska Investment Group L.P.	350,000	$1.87M	0.0%	N/A	0.678%
2/13/2026	Velan Capital Investment Management LP	2,834,652	$15.11M	8.8%	+32.5%	5.490%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
2/13/2026	Charles Schwab Investment Management Inc.	102,499	$546K	0.0%	+7.0%	0.199%
2/13/2026	State Street Corp	570,878	$3.04M	0.0%	+63.1%	1.106%
2/13/2026	Wells Fargo & Company MN	39,802	$212K	0.0%	+60.7%	0.077%
2/12/2026	HRT Financial LP	36,260	$193K	0.0%	N/A	0.070%
2/12/2026	Renaissance Technologies LLC	266,807	$1.42M	0.0%	-15.1%	0.517%
2/12/2026	Dimensional Fund Advisors LP	227,157	$1.21M	0.0%	+376.1%	0.440%
2/12/2026	Marex Group plc	85,250	$454K	0.0%	+283.1%	0.165%
2/12/2026	Informed Momentum Co LLC	103,611	$552K	0.1%	N/A	0.201%
2/12/2026	New York State Common Retirement Fund	15,000	$80K	0.0%	-23.9%	0.029%
2/12/2026	Campbell & CO Investment Adviser LLC	20,551	$110K	0.0%	N/A	0.040%
2/12/2026	Alps Advisors Inc.	42,389	$226K	0.0%	N/A	0.082%
2/12/2026	Monashee Investment Management LLC	125,000	$666K	0.4%	N/A	0.242%
2/12/2026	Nuveen LLC	86,501	$461K	0.0%	-69.5%	0.168%
2/11/2026	Empery Asset Management LP	12,832	$68K	0.1%	N/A	0.025%
2/11/2026	Deutsche Bank AG	25,096	$134K	0.0%	N/A	0.049%
2/10/2026	Cibc World Market Inc.	228,895	$1.22M	0.0%	-16.8%	0.443%
2/10/2026	Goldman Sachs Group Inc.	63,492	$338K	0.0%	+366.6%	0.123%
2/10/2026	AXQ Capital LP	10,815	$58K	0.0%	N/A	0.021%
2/10/2026	Intech Investment Management LLC	13,821	$74K	0.0%	-13.1%	0.027%
2/9/2026	Geode Capital Management LLC	817,196	$4.36M	0.0%	+7.7%	1.583%
2/6/2026	Nano Cap New Millennium Growth Fund L P	35,000	$187K	0.2%	N/A	0.068%
2/4/2026	Bailard Inc.	24,417	$130K	0.0%	-33.4%	0.047%
2/2/2026	Oppenheimer & Co. Inc.	223,767	$1.19M	0.0%	+8.1%	0.433%
1/29/2026	UBS Group AG	1,215,537	$6.48M	0.0%	+44.2%	2.354%
1/29/2026	Almanack Investment Partners LLC.	23,782	$127K	0.0%	+76.2%	0.046%
11/17/2025	Susquehanna International Group LLP	81,203	$353K	0.0%	-61.7%	0.210%
11/17/2025	Millennium Management LLC	688,256	$2.99M	0.0%	+22.0%	1.784%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	14,852	$65K	0.0%	-15.8%	0.038%
11/14/2025	ADAR1 Capital Management LLC	35,223	$153K	0.0%	-71.3%	0.091%
11/14/2025	Two Sigma Investments LP	19,558	$85K	0.0%	+35.8%	0.051%
11/14/2025	Bridgeway Capital Management LLC	44,830	$195K	0.0%	-25.1%	0.116%
11/14/2025	Squarepoint Ops LLC	12,385	$54K	0.0%	-49.2%	0.032%
11/13/2025	UBS Group AG	843,074	$3.67M	0.0%	-25.8%	2.185%
11/13/2025	BNP Paribas Financial Markets	50,455	$219K	0.0%	-67.4%	0.131%
11/12/2025	Dimensional Fund Advisors LP	47,708	$208K	0.0%	-44.1%	0.124%
11/7/2025	GSA Capital Partners LLP	101,488	$441K	0.0%	+9.0%	0.263%
11/7/2025	Vanguard Group Inc.	1,904,156	$8.28M	0.0%	+5.7%	4.935%
11/6/2025	Cibc World Market Inc.	274,994	$1.20M	0.0%	-5.7%	0.713%
11/6/2025	Rhumbline Advisers	34,137	$148K	0.0%	+8.2%	0.088%
11/6/2025	Oppenheimer & Co. Inc.	206,973	$900K	0.0%	-15.9%	0.536%
11/3/2025	New York State Common Retirement Fund	19,700	$86K	0.0%	-41.4%	0.051%
10/30/2025	Bailard Inc.	36,669	$160K	0.0%	+23.2%	0.095%
10/22/2025	Almanack Investment Partners LLC.	13,494	$59K	0.0%	N/A	0.035%
10/7/2025	Assenagon Asset Management S.A.	307,422	$1.34M	0.0%	N/A	0.797%
8/15/2025	Opaleye Management Inc.	855,000	$2.59M	0.5%	-50.6%	2.216%
8/15/2025	Bridgeway Capital Management LLC	59,830	$181K	0.0%	+49.6%	0.155%
8/15/2025	Bank of America Corp DE	181,600	$550K	0.0%	-37.1%	0.471%
8/15/2025	Acorn Capital Advisors LLC	1,752,115	$5.31M	3.5%	+36.9%	4.542%
8/15/2025	Adage Capital Partners GP L.L.C.	400,000	$1.21M	0.0%	N/A	1.037%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	17,635	$53K	0.0%	N/A	0.046%
Iran War Shock: What I Was Told In That Private Meeting (Ad) You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country. Because THIS is the real reason.
8/14/2025	Stempoint Capital LP	1,143,677	$3.47M	1.1%	-3.9%	2.964%
8/14/2025	Velan Capital Investment Management LP	2,139,000	$6.48M	6.4%	+28.3%	5.544%
8/13/2025	Marshall Wace LLP	362,526	$1.10M	0.0%	N/A	0.940%
8/13/2025	Walleye Capital LLC	161,091	$488K	0.0%	-29.8%	0.418%
8/13/2025	Invesco Ltd.	23,935	$73K	0.0%	N/A	0.062%
8/13/2025	New York State Common Retirement Fund	33,600	$102K	0.0%	N/A	0.087%
8/13/2025	Quadrature Capital Ltd	11,591	$35K	0.0%	N/A	0.030%
8/12/2025	American Century Companies Inc.	61,554	$187K	0.0%	+69.8%	0.160%
8/12/2025	JPMorgan Chase & Co.	15,264	$46K	0.0%	N/A	0.040%
8/8/2025	Intech Investment Management LLC	16,111	$49K	0.0%	N/A	0.042%

TARA Institutional Ownership - Frequently Asked Questions

During the previous two years, 84 institutional investors and hedge funds held shares of Protara Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($27.16M), RA Capital Management L.P. ($17.95M), Velan Capital Investment Management LP ($15.11M), Integral Health Asset Management LLC ($11.99M), Toronto Dominion Bank ($11.03M), Blackstone Inc. ($8.87M), and AIGH Capital Management LLC ($8.45M).Learn more on Protara Therapeutics' institutional investors.

38.13% of Protara Therapeutics' stock is owned by institutional investors. Learn more on TARA's institutional investor holdings.

Of the 75 institutional investors that purchased Protara Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($4.18M), Adage Capital Partners GP L.L.C. ($3.69M), Janus Henderson Group PLC ($3.25M), ADAR1 Capital Management LLC ($2.33M), Velan Capital Investment Management LP ($2.26M), Integral Health Asset Management LLC ($2.25M), and Acorn Capital Advisors LLC ($1.75M).

Institutional investors have bought a total of 14,888,655 shares in the last 24 months. This purchase volume represents approximately $78.18M in transactions.

Of the 18 institutional investors that sold Protara Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($507.67K), UBS Group AG ($292.69K), ADAR1 Capital Management LLC ($283.75K), Nuveen LLC ($196.98K), Renaissance Technologies LLC ($188.60K), Susquehanna International Group LLP ($130.79K), and BNP Paribas Financial Markets ($104.21K).

Institutional investors have sold a total of 1,968,880 shares in the last 24 months. This volume of shares sold represents approximately $8.95M in transactions.

Related Companies

Institutional ownership data for NASDAQ:TARA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/18/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Protara Therapeutics (TARA) Institutional Ownership

TARA Institutional Buying and Selling by Quarter

Protara Therapeutics Major Shareholders & Ownership History

TARA Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Protara Therapeutics (TARA) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Protara Therapeutics (NASDAQ:TARA)

TARA Institutional Buying and Selling by Quarter

Protara Therapeutics Major Shareholders & Ownership History

TARA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TARA shares?

What percentage of Protara Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Protara Therapeutics' stock?

How much institutional buying is happening at Protara Therapeutics?

Which of Protara Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Protara Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools